3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase EARLY_PHASE1
1
Phase 4
1
Phase 3
1
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Cancer Pain
1
Interventions
Dexamethasone
13
Saline Solution
8
Bupivacaine
8
Bevacizumab
8
Tobacco Use Cessation Devices
7
Specimen Handling
7
Nivolumab
7
Magnetic Resonance Spectroscopy
7
Lenalidomide
7
Fluorouracil
7
pembrolizumab
6
Rituximab
6
Prednisone
6
Letrozole
6
Carboplatin
6
Propofol
5
Human Papillomavirus Recombinant Vaccine nonavalent
5
trametinib
4
lenvatinib
4
dabrafenib
4
cabozantinib
4
anlotinib
4
Trastuzumab
4
Tamoxifen
4
Standard of Care
4
Sodium Chloride
4
Ropivacaine
4
Paclitaxel
4
Immune Checkpoint Inhibitors
4
Esomeprazole
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Oxycodone
×
1 year
×
Clear all
NCT07001709
2025-06-03
ENABLE
Deventer Ziekenhuis
Phase 4
Recruiting
29 enrolled